Stereotactic Body Radiotherapy (SBRT) Plus Immunotherapy for Cancer

NCT03431948 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Cancer

Interventions

DRUG: Nivolumab
DRUG: Cabiralizumab
DRUG: Urelumab
RADIATION: Stereotactic Body Radiation Therapy

Sponsor

University of Chicago

Collaborators

[object Object]